111 related articles for article (PubMed ID: 1846343)
1. Significance of anti-HBx antibodies in hepatitis B virus infection.
Levrero M; Stemler M; Pasquinelli C; Alberti A; Jean-Jean O; Franco A; Balsano C; Diop D; Brechot C; Melegari M
Hepatology; 1991 Jan; 13(1):143-9. PubMed ID: 1846343
[TBL] [Abstract][Full Text] [Related]
2. Detection of antibodies to proteins encoded by the X-region of hepatitis B virus (HBV) in sera of patients with chronic HBV infection: correlation with other HBV markers.
Theilmann L; Salfeld J; Kommerell B; Pfaff E
Hepatogastroenterology; 1988 Jun; 35(3):104-6. PubMed ID: 3402900
[TBL] [Abstract][Full Text] [Related]
3. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
4. [Seroepidemiological study of hepatitis B virus x antigen (HBxAg) and anti-HBx antibodies in patients with hepatitis B].
Wu Z
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Aug; 13(4):205-7. PubMed ID: 1301263
[TBL] [Abstract][Full Text] [Related]
5. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
6. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis B virus: new markers and their immunology].
Lega L; Resti M; Rossi ME; Azzari C; Botarelli P; Vierucci A
Pediatr Med Chir; 1993; 15(1):5-10. PubMed ID: 8488126
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
9. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
10. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
[TBL] [Abstract][Full Text] [Related]
11. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity.
Haushofer AC; Hauer R; Brunner H; Köller U; Trubert-Exinger D; Halbmayer WM; Koidl C; Kessler HH
J Clin Virol; 2004 Apr; 29(4):221-3. PubMed ID: 15018848
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis B virus DNA detection by means of polymerase chain reaction in patients with chronic hepatitis and hepatocellular carcinoma].
Song Y; Pan W; Fan Z; Du P; Qi Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):220-2. PubMed ID: 15617333
[TBL] [Abstract][Full Text] [Related]
13. [Significance of "anti HBC alone" serological profile in 284 patients suspicious of being infected with hepatitis B virus].
Berrajah-Fki L; Ben Halima S; Guermazi F; Hammami A; Karray-Hakim H
Ann Biol Clin (Paris); 2006; 64(5):451-5. PubMed ID: 17040876
[TBL] [Abstract][Full Text] [Related]
14. Occult hepatitis B virus infection.
Allain JP
Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
[TBL] [Abstract][Full Text] [Related]
15. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.
Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L
Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
[TBL] [Abstract][Full Text] [Related]
17. Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma.
Ohba K; Kubo S; Tamori A; Hirohashi K; Tanaka H; Shuto T; Nishiguchi S; Kinoshita H
Surg Today; 2004; 34(10):842-8. PubMed ID: 15449154
[TBL] [Abstract][Full Text] [Related]
18. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
Tamori A; Hayashi T; Shinzaki M; Kobayashi S; Iwai S; Enomoto M; Morikawa H; Sakaguchi H; Shiomi S; Takemura S; Kubo S; Kawada N
J Med Virol; 2009 Jun; 81(6):1009-14. PubMed ID: 19382258
[TBL] [Abstract][Full Text] [Related]
19. Excess HBcAg in HBc antibody-negative chronic hepatitis B virus carriers.
Lazizi Y; Dubreuil P; Pillot J
Hepatology; 1993 Jun; 17(6):966-70. PubMed ID: 8514269
[TBL] [Abstract][Full Text] [Related]
20. [Anti-HBc within the framework of hepatitis B virus infection: correlation to the form of inflammation and to the viral expression].
Endo Y; Gudat F; Bianchi L; Mihatsch M; Gasser M; Stalder GA; Schmid M
Schweiz Med Wochenschr; 1978 Mar; 108(10):363-73. PubMed ID: 625636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
